Tuesday 1 April 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Opthea
A biopharmaceutical company developing novel therapies for retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).
Pharmaceutical
Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk
28 March 2025
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024

Latest Ones To Watch News

Pharmaceutical
Spanish cancer start-up Nuage swiches CEO
1 April 2025
Biotechnology
End of the line for Inspirna as biotech sector faces strain
1 April 2025
Biotechnology
ProBioGen appoints Alfred Merz as chief executive
31 March 2025
More ones to watch news >
Reset all filters
Refine Search
Soleno Therapeutics
Soleno Therapeutics
GAIA
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience
Atopia Therapeutics
Prologue Medicines
Lykos Therapeutics


Today's issue

Spanish cancer start-up Nuage swiches CEO
Pharmaceutical
Spanish cancer start-up Nuage swiches CEO
1 April 2025
Biotechnology
End of the line for Inspirna as biotech sector faces strain
1 April 2025
Pharmaceutical
AstraZeneca’s AZD0780 shows ‘potential to be a game changer’
1 April 2025
Pharmaceutical
Latest Teva data in schizophrenia for long-acting injectable of olanzapine
1 April 2025
Biosimilars
Bio-Thera and Dr Reddy’s sign biosimilars deal
1 April 2025
Biotechnology
EC refers lecanemab decision to Appeal Committee
1 April 2025
Pharmaceutical
Further Winrevair PAH results revealed at ACC
1 April 2025

Company Spotlight

A biopharmaceutical company developing novel therapies for retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze